Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson’s disease without cognitive impairment

DOI: 10.1186/s40814-017-0154-7

Keywords: Feasibility study, Crossover, Medication withdrawal, Pramipexole PR, Ropinirole MR, Idiopathic Parkinson’s disease, Cued recall, Safety processes, Acceptability, Barriers to participation

Full-Text   Cite this paper   Add to My Lib

Abstract:

CONSORT diagram showing key stages of study desig

Full-Text